BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24549671)

  • 1. Antisense methods to modulate pre-mRNA splicing.
    Seo J; Ottesen EW; Singh RN
    Methods Mol Biol; 2014; 1126():271-83. PubMed ID: 24549671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-mRNA Splicing Modulation by Antisense Oligonucleotides.
    Singh NN; Luo D; Singh RN
    Methods Mol Biol; 2018; 1828():415-437. PubMed ID: 30171557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulating full-length SMN2 expression by delivering bifunctional RNAs via a viral vector.
    Baughan T; Shababi M; Coady TH; Dickson AM; Tullis GE; Lorson CL
    Mol Ther; 2006 Jul; 14(1):54-62. PubMed ID: 16580882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements.
    Recinos Y; Ustianenko D; Yeh YT; Wang X; Jacko M; Yesantharao LV; Wu Q; Zhang C
    Nat Commun; 2024 May; 15(1):3839. PubMed ID: 38714659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing.
    Singh NN; Hollinger K; Bhattacharya D; Singh RN
    RNA; 2010 Jun; 16(6):1167-81. PubMed ID: 20413618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed
    Wijaya YOS; Niba ETE; Nishio H; Okamoto K; Awano H; Saito T; Takeshima Y; Shinohara M
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of trans-acting elements that promote exon 7 skipping of SMN2 in SMN2-GFP stable cell line.
    Cho S; Moon H; Yang X; Zhou J; Kim HR; Shin MG; Loh TJ; Zheng X; Shen H
    Biochem Biophys Res Commun; 2012 Jul; 423(3):531-5. PubMed ID: 22683329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1.
    Irimura S; Kitamura K; Kato N; Saiki K; Takeuchi A; Gunadi ; Matsuo M; Nishio H; Lee MJ
    Kobe J Med Sci; 2009 Mar; 54(5):E227-36. PubMed ID: 19628962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
    Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
    J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intronic element contributes to splicing repression in spinal muscular atrophy.
    Kashima T; Rao N; Manley JL
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1.
    Cartegni L; Krainer AR
    Nat Genet; 2002 Apr; 30(4):377-84. PubMed ID: 11925564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxycycline-controlled splicing modulation by regulated antisense U7 snRNA expression cassettes.
    Marquis J; Kämpfer SS; Angehrn L; Schümperli D
    Gene Ther; 2009 Jan; 16(1):70-7. PubMed ID: 18701908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMN in spinal muscular atrophy and snRNP biogenesis.
    Coady TH; Lorson CL
    Wiley Interdiscip Rev RNA; 2011; 2(4):546-64. PubMed ID: 21957043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is RNA manipulation a viable therapy for spinal muscular atrophy?
    Horne C; Young PJ
    J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of minigene systems to dissect alternative splicing elements.
    Cooper TA
    Methods; 2005 Dec; 37(4):331-40. PubMed ID: 16314262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome.
    Ottesen EW; Luo D; Singh NN; Singh RN
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic oligonucleotides recruit ILF2/3 to RNA transcripts to modulate splicing.
    Rigo F; Hua Y; Chun SJ; Prakash TP; Krainer AR; Bennett CF
    Nat Chem Biol; 2012 Apr; 8(6):555-61. PubMed ID: 22504300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing therapeutics in SMN2 and APOB.
    Khoo B; Krainer AR
    Curr Opin Mol Ther; 2009 Apr; 11(2):108-15. PubMed ID: 19330716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic characterization of short intronic splicing-regulatory elements in SMN2 pre-mRNA.
    Gao Y; Lin KT; Jiang T; Yang Y; Rahman MA; Gong S; Bai J; Wang L; Sun J; Sheng L; Krainer AR; Hua Y
    Nucleic Acids Res; 2022 Jan; 50(2):731-749. PubMed ID: 35018432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.